NRAS status determines sensitivity to SHP2 inhibitor...

  • Main
  • 2020 / 06
  • NRAS status determines sensitivity to SHP2 inhibitor...

NRAS status determines sensitivity to SHP2 inhibitor combination therapies targeting the RAS-MAPK pathway in neuroblastoma

Valencia-Sama, Ivette, Ladumor, Yagnesh, Kee, Lynn, Adderley, Teresa, Christopher, Gabriella, Robinson, Claire M., Kano, Yoshihito, Ohh, Michael, Irwin, Meredith S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-19-3822
Date:
June, 2020
File:
PDF, 2.18 MB
2020
Conversion to is in progress
Conversion to is failed